Huperzine A: Research, Dosing, and Where to Buy in 2026
A research-first profile for Huperzine A, aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
Huperzine A is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 15 PubMed-cited papers, 2 attributed expert mentions, and 1 transcript dosing protocol for Huperzine A, each linked to its source.
- 1 aggregated dosing-protocol mention from source transcripts.
- 15 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
- Evidence level in this entry is marked as research.
What is Huperzine A?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
Experts on background and overview · 1 cited mention
"obviously people have taken huperzine A with alpha GPC to prolong the lifetime of the acetylcholine that's made."
How does Huperzine A work?
Experts on mechanism · 1 cited mention
"Inducing neuron outgrowth very similar to other nootropics like [huperzine] acetylcholine influencing various neuro trophic factors like BDNF."
What is Huperzine A researched for?
An acetylcholinesterase inhibitor used as a memory and cognition enhancer that induces neurite outgrowth.
Huperzine A Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
| Speaker | Source | Timestamp | Protocol | Evidence |
|---|---|---|---|---|
| Lucy | How to Reduce Anxiety | These 2 Amino Acids Will Relax You | 00:10:31 | Lucy reported using 50-100 micrograms daily, taken in the morning or early afternoon to avoid hampering sleep. She employed a cyclical approach: 2-4 weeks on followed by a pause. Side effects she monitored for included nausea and sleep disturbances. | anecdotal |
Where to Buy Huperzine A in 2026
No tracked vendor recommendations for Huperzine A yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
What Experts Say
2 experts across our source library discuss Huperzine A. Each entry is that expert’s most context-rich mention: click to watch it at the exact timestamp in the original video. Quotes are also emitted as Schema.org Quotation JSON-LD for AI assistants.
-
“obviously people have taken huperzine A with alpha GPC to prolong the lifetime of the acetylcholine that's made.”
-
“Inducing neuron outgrowth very similar to other nootropics like [huperzine] acetylcholine influencing various neuro trophic factors like BDNF.”
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about Huperzine A. Each line links to the original source.
- "This nanozyme was integrated with AChE to construct a dual-enzyme cascade biosensing platform, which achieved highly sensitive AChE detection, with a detection limit of 0.01 mU/mL, and demonstrated excellent accuracy in fetal bovine serum (spiked recoveries: 92.07-111.09%)." · Cai S et al, 2026 PubMed
- "The UAE-obtained extract of Poria cocos (Yunnan) showed the strongest inhibition, achieving an AChE inhibition rate of 39.03% at 0.01 mg/mL." · Cai S et al, 2026 PubMed
- "Notably, ST demonstrated a strong radical scavenging activity, reaching 93.23% (DPPH at 0.2 μg/mL) and 99.87% (ABTS at 4 μg/mL), and reduced nitrite production from 10.29 μM to 6.51 μM at 50 µg/mL." · Huang Y et al, 2026 PubMed
- "In addition, the HupA content in ST reached 36.56% of that found in WH." · Huang Y et al, 2026 PubMed
- "This microbubble-mediated propulsion mechanism achieved a 50% increase in penetration depth (up to ∼ 1428 µm) relative to conventional microneedle platforms." · Shen S et al, 2026 PubMed
- "**RESULTS**: The trial recruited 127 patients, of which 123 patients were included in the full analysis set (76 females [61.8%]; mean [SD] age, 59.6 [12.6] years)." · Zhang Z et al, 2025 PubMed
- "There were 58 patients in intervention group (40 females [69.0%]; mean [SD] age, 59.6 [11.9] years) and 65 in non-intervention group (36 females [55.4%]; mean [SD] age, 59.7 [13.2] years)." · Zhang Z et al, 2025 PubMed
Research and Studies
15 PubMed-indexed papers reference Huperzine A. Top 15 shown.
Legal Status
Huperzine A is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is Huperzine A FDA-approved?
Huperzine A is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
What dosing is reported for Huperzine A?
This page aggregates 1 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.
How much research has been published on Huperzine A?
15 PubMed-indexed paper(s) reference Huperzine A in our current research feed. See the Research and Studies section above for citations.